1. Home
  2. OLP vs NBY Comparison

OLP vs NBY Comparison

Compare OLP & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Liberty Properties Inc.

OLP

One Liberty Properties Inc.

HOLD

Current Price

$21.31

Market Cap

478.2M

Sector

Real Estate

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

SELL

Current Price

$2.98

Market Cap

398.2M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
OLP
NBY
Founded
1982
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
478.2M
398.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
OLP
NBY
Price
$21.31
$2.98
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
138.0K
583.6K
Earning Date
11-06-2025
11-07-2025
Dividend Yield
8.38%
N/A
EPS Growth
N/A
N/A
EPS
1.54
0.47
Revenue
$97,423,000.00
$10,302,000.00
Revenue This Year
$7.95
$23.91
Revenue Next Year
$6.06
$32.05
P/E Ratio
$13.96
$136.00
Revenue Growth
9.29
390.34
52 Week Low
$19.62
$0.46
52 Week High
$29.23
$4.44

Technical Indicators

Market Signals
Indicator
OLP
NBY
Relative Strength Index (RSI) 62.54 74.54
Support Level $20.90 $2.66
Resistance Level $21.25 $1.11
Average True Range (ATR) 0.34 0.46
MACD 0.10 0.21
Stochastic Oscillator 84.39 66.03

Price Performance

Historical Comparison
OLP
NBY

About OLP One Liberty Properties Inc.

One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: